Macrogenics, Inc.
CAGE Code: 3PTZ3
NCAGE Code: 3PTZ3
Status: Active
Type: Manufacturer
Dun & Bradstreet (DUNS): 010626351
Summary
Macrogenics, Inc. is an Active Manufacturer with the Cage Code 3PTZ3 and is tracked by Dun & Bradstreet under DUNS Number 010626351..
Address
9704, Medical Center Drive
Rockville MD 20850-3343
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Dansources Technical Services, Inc. Linda Fang Ht Medical Systems Inc Stream Intl Inc Air Services Inc Lcg Inc Social And Health Services Ltd S.S. Papadopulos & Associates, Inc. Twinbrook Tv And Computer Covington Sharon N Dictaphone Corp Sgl Industries Inc Selecter Div Polytronic Research Inc White Flint Pharmacy Inc Copy Supply Llc Wardwell Richard E Inc Tec Inc Sporicidin International Computer Pros Inc Dally James
Frequently Asked Questions (FAQ) for CAGE 3PTZ3
- What is CAGE Code 3PTZ3?
- 3PTZ3 is the unique identifier used by NATO Organizations to reference the physical entity known as Macrogenics, Inc. located at 9704, Medical Center Drive, Rockville MD 20850-3343, United States.
- Who is CAGE Code 3PTZ3?
- 3PTZ3 refers to Macrogenics, Inc. located at 9704, Medical Center Drive, Rockville MD 20850-3343, United States.
- Where is CAGE Code 3PTZ3 Located?
- CAGE Code 3PTZ3 is located in Rockville, MD, USA.
Contracting History for CAGE 3PTZ3 Most Recent 25 Records
- 36F79721D0254
- Administrative Modification - Poc Change And New Agent Authorization
- 24 Mar 2023
- Administrative Modification - Poc Change And New Agent Authorization
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79721D0254
- 2024 Public Law Pricing Updates
- 2 Nov 2023
- 2024 Public Law Pricing Updates
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79721D0254
- 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, Fss Contract Award
- 8 Sep 2021
- 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, Fss Contract Award
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79721D0254
- Lifecycle Update
- 22 Oct 2021
- Lifecycle Update
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79721D0254
- 2022 Public Law Pricing Updates
- 30 Nov 2021
- 2022 Public Law Pricing Updates
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79721D0254
- Administrative Modification - Technical
- 23 Aug 2022
- Administrative Modification - Technical
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79721D0254
- 2023 Pl Update.
- 21 Nov 2022
- 2023 Pl Update.
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- HHSN272201500032C
- The Objectives Of This Contract Are To Perform Product Development And Advance Therapeutic Products, Dual Affinity Re-Targeting (Dart)-1 And Dart-2, Into Phase 1/2 Clinical Trials For Use As Therapeutic Agents, In Combination With Latency Reversing T
- 13 Jul 2021
- The Objectives Of This Contract Are To Perform Product Development And Advance Therapeutic Products, Dual Affinity Re-Targeting (Dart)-1 And Dart-2, Into Phase 1/2 Clinical Trials For Use As Therapeutic Agents, In Combination With Latency Reversing T
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $25,119,949.00
- Department Of Health And Human Services (Hhs)
- HHSN272201500032C
- Eo14042 - Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- 5 Nov 2021
- Eo14042 - Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $25,119,949.00
- Department Of Health And Human Services (Hhs)
- 36F79721D029E
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- 29 Jul 2021
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- 36F79721D029E
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- 14 Sep 2021
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- HHSN272201500032C
- Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- 9 Sep 2022
- Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $25,119,949.00
- Department Of Health And Human Services (Hhs)
- 36F79721D029E
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- 17 Mar 2021
- Interim Agreement Under Fss Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products
- Nac Federal Supply Schedule (36F797)
- Department Of Veterans Affairs (Va)
- $0.00
- Department Of Veterans Affairs (Va)
- HHSN272201500032C
- Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- 23 Feb 2022
- Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $25,119,949.00
- Department Of Health And Human Services (Hhs)
- HHSN272201500032C
- Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- 7 Jun 2022
- Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $25,119,949.00
- Department Of Health And Human Services (Hhs)
- HHSN272201500032C
- Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- 3 Jul 2023
- Dual Affinity Re-Targeting Molecules For Hiv-1 Suppression
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $25,119,949.00
- Department Of Health And Human Services (Hhs)